FDA Approved Abbott BLA for Hepatitis B Virus Core Antigen

FDA approved Abbott’s BLA for the hepatitis B virus core antigen, according to a statement from the regulator.

• Abbott’s Alinity s Anti-HBC assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of antibody to hepatitis B core antigen (anti-HBc) in human serum and plasma specimens on the Alinity s System
• NOTE: July 11, Abbott Gets FDA Approval for Blood Screening Alinity S System

©2019 Bloomberg L.P. All rights reserved. Used with permission